# AQUAPASS REFORM-HF Pivotal Trial Meets Primary Endpoint, Demonstrating Significant Fluid Removal in Heart Failure Patients

- Source: PR Newswire M&A
- Published: 2026-11-05T14:21:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/aquapass-reform-hf-pivotal-trial-meets-primary-endpoint-demonstrating-significant-fluid-removal-in-heart-failure-patients-302930870.html
- Canonical: https://groundlevelnews.com/story/aquapass-reform-hf-pivotal-trial-meets-primary-endpoint-demonstrating--4d44be/

AQUAPASS ECCON™ System delivered a >7x increase in net fluid loss in congested heart failure patients not responding to high-dose diuretics, with a consistently high responder rate (91%) and no device-related adverse events NEWTON, Mass., Nov. 5, 2026 /PRNewswire/ -- AQUAPASS Medical,...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._